HSKA Stock Price, Chart, Stats & News

Heska Corporation
Save
1.31B
Market cap
–
Current P/E
–
Forward P/E
HSKA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 43.20% |
Operating margin | -7.89% |
Pretax margin | -8.49% |
Net margin | -7.16% |
Effective tax rate | 15.62% |
ROA | -3.15% |
ROE | -4.29% |
D/E | 0.24x |
Interest coverage ratio | -13.21x |
HSKA valuation
P/E | – |
P/S | 5.09x |
P/B | 2.94x |
P/CF | -56.90x |
P/FCF | -54.73x |
P/OCF | -56.90x |
PEG | -0.67x |
EV multiple | -67.15x |
About
Heska Corporation provides specialized diagnostic and animal health products, predominantly for canine and feline veterinary care markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Its product line includes a variety of veterinary chemistry analyzers: the Element DC, DCX, and DC5x series, along with the Element RC, RCX, and RC3X systems, all tailored for blood chemistry and electrolyte analysis. For hematological assessments, Heska offers the Element HT5 and scil Vet abc Plus analyzers, capable of measuring blood cell and platelet counts, as well as hemoglobin levels.
Similar securities
Based on sector and market capitalization
Report issue











